Pluristem Therapeutics, Inc. (PSTI)

Company Overview

Pluristem Therapeutics, Inc. is a biotechnology company that develops cell therapy products to treat severe blood, cardiovascular, autoimmune, and other disorders. Cell therapy is a technology that relies on replacing diseased or dysfunctional cells with healthy, functioning ones.

The Company’s first planned product, PLX-I, is intended to resolve the global shortage of matched tissue for bone marrow transplantation. PLX II is being developed as a personalized product for patients in need of a bone marrow transplant who have available autologous umbilical cord blood. Pluristem believes their future products will participate in the approximate $30 billion therapeutic and re...

read more


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: MATAM Advanced Technology Park, Building No 20, Haifa, 31905, Israel
Mailing Address: -
Phone: 972 7 4710 7171
Fax: 972 7 4710 7172
Website: http//

Company Details:

Symbol: PSTI
SIC: 7374
State location: L3
Sector: -
State of Inc: NV
Employees: 44
Type: -

Key executives:

Name Age Position